baber/WOPTO huggingface dataset:
Patent ES-531880-A0 (ES)
IPC: C22B13/00
Filed: 1984-04-25
Abstract: The invention relates to a method for producing lead having a sulphur content beneath about 2%, from sulphur-containing oxidic lead raw materials contaminated with zinc and/or other readily oxidized elements, by smelting the materials in afurnace in which furnace contents can be agitated. When practicing the method, the lead raw materials are charged to the furnace together with iron-containing fluxes and solid reduction agents. The charged materials are heated under agitation, to form a lead phase and a slag phase. The amount of reduction agent charged is selected so that at least all the lead contained in the furnace is reduced to lead metal and the amount and composition of the fluxes are selected so that a terminal slag is obtained in which the sum of the iron and zinc present is 30-40%, and so that the slag has a content of 15-25% of both Si0<sub>2</sub> and CaO + MgO.Lead raw materials, fluxes and reduction agents are suitably introduced in a plurality of charges, with intermediate moderate heating, prior to commencing the smelting process.
Patent ES-538863-A0 (ES)
IPC: A61L15/24
Filed: 1984-12-20
Abstract: In a therapeutic system such as a plaster for administration of an active compound through the skin and comprising a covering layer which is essentially impermeable to the active compound, an active coupound reservoir layer and a protective layer which can be pulled off and which is essentially impermeable to the active compound, the improvement wherein the reservoir layer contains about 1-30% of active compound in an elastomer mixture comprising a diene rubber which can optionally be copolymerized with an  alpha -olefin, mixed with from 0 up to about 70% by weight of a polyisobutylene, polybutadiene oil and/or paraffin oil, and a tackifying resin. Thereby the active compound can be released in regulated relatively large quantity over a prolonged period of time.
Patent ES-547992-A0 (ES)
IPC: C11D3/39
Filed: 1985-10-18
Abstract: 1. Process for the preparation of stabilised, substituted diperoxysuccinic acids by reacting an anhydride of the formula  see diagramm : EP0179223,P3,F1  in which R denotes a linear or branched alkyl radical having 4 to 20 C atoms or aryl, with an oxidation mixture consisting of hydrogen peroxide, water and sulphuric acid, using a molar ratio of hydrogen peroxide to anhydride of 2 up to 20 to 1, at 20-90 degrees C, characterized in that sulphuric acid and the anhydride are employed for the reaction in a molar ratio of 2 up to 10 to 1, and the anhydride is suspended in the oxidation mixture and the stabilisation is effected using sodium sulphate formed in situ as a stabilising agent, by adjusting the pH to a value of 2 to 6 by adding sodium hydroxide or sodium carbonate solution at temperatures above 32.4 degrees C, and thus converting at least a fraction of the sulphuric acid present in the reaction mixture into sodium sulphate, and working up the reaction product in a known manner.
Patent ES-554449-A0 (ES)
IPC: A61K38/00
Filed: 1986-04-28
Abstract: A cDNA sequence encoding active human uterine TPA.
Patent ES-555843-A0 (ES)
IPC: H01H71/52
Filed: 1986-06-06
Abstract: A moulded case circuit breaker has a toggle-joint mechanism, articulated on a hook and on a moving contact support. The toggle joint includes a swivel pin movably engaged in an aperture of the hook. When tripping takes place, the released hook pushes the toggle-joint, via the swivel pin and aperture, into a broken position to accelerate opening of the contacts. In the closed position, the toggle-joint is practically perpendicular to the hook.
Patent FI-874640-A0 (FI)
Inventor: WAGNER FRIEDRICH
IPC: E03C1/084
Filed: 1987-10-21
Abstract: 1. A discharge nozzle for sanitary fittings with an aerating means having a nozzle floor and air-admission channels to produce a mixture of water and air, wherein there are provided several substantially flat sieves arranged at intervals from one another behind the aerating means and the sieve (6) positioned downstream has the largest mesh width, characterized in that the sieve (6) arranged downstream has an inside mesh width of about 1.2 mm to 5 mm, preferably rectangular meshes of an inside mesh width of about 1.5 mm x 1.5 mm, and the sieve or sieves (5) arranged upstream have an inside mesh width of about 0.5 x 0.5 mm.
Patent FI-880181-A0 (FI)
Inventor: WILSON ROBERT THOMAS
IPC: F16K1/22
Filed: 1988-01-15
Abstract: An improved joint connection between a rotary valve shaft (12) and valve closure member (10) for a fluid valve. A tapered key (24) has a flat surface (26) tapered at a small angle with respect to the opposite key surface. The rotary valve shaft (12) includes a groove (32) with a flat surface. The tapered key (24) is wedged into a passageway in the valve closure member to form an interference fit between the closure member (10), key (24) and shaft (12).
Patent FI-893134-A0 (FI)
Inventor: KRUPP STEPHEN P
IPC: C08L23/04
Filed: 1989-06-27
Abstract: Blends of high molecular weight linear polyethylene and low molecular weight linear polyethylene provide improved fiber-forming capabilities over that found with either polymer taken alone. Preferably at least one of the polymers used in the blend is a linear low density polyethylene, LLDPE, which is a linear polyethylene comprising ethylene copolymerized with an amount of a higher alpha-olefin which causes the density of the copolymer to be less than that of a homopoly-mer made using the same process and catalyst. The higher alpha-olefin can be at least one in the C3-C12 range, preferably in the C4-C8 range.
Patent FI-901671-A0 (FI)
Inventor: WOLFF ROBERT
IPC: B25H1/10
Filed: 1990-04-03
Abstract: A work-table equipped to be a workbench and at the same time a circular-saw table possesses a table area which is divided into a workbench plate and a circular-saw clamping plate, the clamping plate being pivotable relative to the workbench plate. The work-table is, on the one hand, to be collapsible to form a flat package and, on the other hand, stable and braced rigidly per se in the unfolded position. For this purpose, the work-table has a common upper frame (1) carrying the workbench plate (2) and the clamping plate (3), the legs (17, 18, 19, 20) are articulated to the upper frame (1) only in the region of the workbench plate (2), are connected in pairs by a coupling rod (23, 24) and can be folded under the clamping plate (3), the clamping plate (3) can be folded back until it is in an inclined position above the workbench plate (2), and the workbench has, on its side facing away from the clamping plate (3), a clamping device (11) for clamping tools. 
<IMAGE>
Patent FI-903775-A0 (FI)
Inventor: LEMAIRE JACQUES
IPC: C14C9/00
Filed: 1990-07-27
Abstract: Method for the antifungal and/or antibacterial treatment of hides.   This method consists in treating these hides with a bath containing a lanthanum or cerium salt, for example a lanthanum acrylate.
Patent FI-914014-A0 (FI)
Inventor: NOVEROLA ARMANDO VEGA
IPC: A61K9/08
Filed: 1991-08-26
Abstract: Xanthines of the general formula: <CHEM> wherein R<1> represents a straight or branched chain alkyl, alkenyl or alkynyl group of 3-6 carbon atoms, and R<2> and R<3>, which may be the same or different, each represent hydrogen or halogen or a methyl, methoxy, nitro or trifluoromethyl group or R<2> and R<3> together form a methylenedioxy or ethylenedioxy group; with the proviso that R<2> and R<3> are not both hydrogen; and pharmacologically acceptable salts thereof with an alkali metal base or a nitrogen base containing organic base, are bronchodilators making them of value in treating asthma and vasodilators making them of interest in treating angina, hypertension, congestive heart failure and multi-infarct dementia. The compounds are also of use in combatting other conditions where inhibition of PDE type IV is thought to be beneficial. The compounds can be prepared by treating the corresponding 6-amino uracil with sodium nitrite and formic acid in an excess of formamide and adding sodium dithionate to reduce the resulting 6-amino-5-nitroso compound to give the 5,6-diamino compound that ring closes with the excess of formamide.
Patent FI-931674-A0 (FI)
Inventor: VEIJALAINEN VESA
IPC: H02H7/085
Filed: 1993-04-14
Abstract: PCT No. PCT/FI94/00137 Sec. 371 Date Sep. 19, 1995 Sec. 102(e) Date Sep. 19, 1995 PCT Filed Apr. 12, 1994 PCT Pub. No. WO94/24750 PCT Pub. Date Oct. 27, 1994The invention relates to a method of monitoring a temperature rise of a stator winding of a squirrel cage induction motor, in which method a stator current I of the motor is measured and the temperature rise of the motor at each moment is determined on the basis of this current I, when a rated temperature rise  theta N of the motor at a rated current IN, the rated current IN and a temperature rise time constant  tau  of the motor are known. The method comprises steps of determining the stator current I of the motor as discrete moments separated by  DELTA t long time periods, determining the temperature rise  theta n(1) of the motor during one time period n from the equation   <IMAGE>   determining a cooling  theta n(2) of the motor during the same time period n from the equation theta n(2)= theta n-1e- DELTA t/ tau ,where  theta n-1 is the temperature rise of the motor at the end of the preceding time period, and summing the temperature rise  theta n(1) and the cooling  theta n(2) occurred during the same time period to obtain the temperature rise  theta N of the motor at the end of the time period n.
Patent FI-935845-A0 (FI)
Inventor: TARALDSSON LEIF BOERJE
IPC: E04G9/05
Filed: 1993-12-23
Abstract: PCT No. PCT/SE92/00473 Sec. 371 Date Dec. 21, 1993 Sec. 102(e) Date Dec. 21, 1993 PCT Filed Jun. 25, 1992 PCT Pub. No. WO93/00494 PCT Pub. Date Jan. 7, 1993.A mould-form shuttering panel against which concrete is intended to be cast. The shuttering panel is wood based, such as plywood, wherein the side of the shuttering panel intended to lie in contact with the concrete includes an elastic layer which will not adhere to the concrete to any significant extent. The elastic layer is 1-5 mm in thickness and is applied to the plywood by a method including spraying the layer onto the plywood and then rolling a roller over the liquid coating.
Patent FI-941122-A0 (FI)
Inventor: MOLOCK FRANK F
IPC: C08G65/32
Filed: 1994-03-09
Abstract: A soft hydrogel contact lens, is disclosed. The lens is derived from a crosslinked polymer comprising the reaction product of a monomer mixture comprising:     (A) a monounsaturated polyoxyethylene monomer; (B) a diunsaturated polyoxyethylene monomer of relatively high molecular weight; (C) a diunsaturated polyoxyethylene monomer of relatively low molecular weight; and (D) a hydrophilic monomer selected from the group consisting of hydroxyethyl methacrylate, methacrylic acid, N,N-dimethyl-acrylamide, N-vinyl pyrrolidone, glycerol monomethacrylate, itaconic acid, and mixtures thereof.
Patent FI-946083-A0 (FI)
Inventor: TERRETT NICHOLAS KENNETH
IPC: A61P9/00
Filed: 1994-12-23
Abstract: Compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R<1> is C1-C4 alkyl; R<2> is C2-C4 alkyl; R<3> is H or SO2NR<4>R<5>; R<4> and R<5> together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino, morpholino or 4-N-(R<6>)-1-piperazinyl group; and R<6> is H or C1-C3 alkyl; are selective cGMP PDE inhibitors useful in the treatment of, inter alia, cardiovascular disorders such as angina, hypertension, heart failure and atherosclerosis.
Patent FI-951416-A0 (FI)
Inventor: YOSHINO HIROSHI
IPC: C07D219/04
Filed: 1995-03-24
Abstract: Novel antitumor sulfonamide and sulfonic ester derivatives each having a tricyclic hetero ring, represented by general formula (I), and a process for producing the same, wherein G represents a 5- or 6-membered aromatic ring; L represents O or NR<1>, wherein R<1> represents hydrogen or lower alkyl; and M represents a tricyclic structure selected from the members (a), (b), (c), (d), (e), (f), wherein rings A and B represent each a 5- or 6-membered unsaturated ring; X represents NR<2> (wherein R<2> represents hydrogen or lower alkyl) or NHCO; Y represents O, S(O)n, CR<3>R<4>, CO, NR<5>, CHR<6>CHR<7>, CR<8>=CR<9>, NR<1><0>CO, N=CR<1><1>, OCHR<1><2>, S(O)nCHR<1><3> or NR<1><4>CHR<1><5>; and Z represents N or CR<1><6>, wherein n represents 0, 1 or 2; R<3>-R<1><3>, R<1><5> and R<1><6> represent each hydrogen or lower alkyl; and R<1><4> represents hydrogen, lower alkyl or lower acyl. <CHEM>
Patent IL-74259-A0 (IL)
Title: Improved method for cell culture
IPC: C12N1/00
Filed: 1985-02-05
Abstract: Processes for the surface culture of eukaryotic and procaryotic cells on solid carriers. The growth cells are cultured on or in the presence of a solid carrier coated with surface active molecules which act as a major carbon- and energy source. The surface active molecules which have very low solubility in an aqueous solution, are hold in position at the solid surface by hydrophobic forces. The process can be considered as an immobilization of the surface active molecules. The surface active molecules include phospholipids, triglycerides, fatty acids, proteins, synthetic peptides and sterol. The aqueous medium can be any convenient medium without foetal calf serum or albumin-compounds or with reduced amounts of these. The invention also includes products for healing skin leasions.
Patent IL-80539-A0 (IL)
Title: Autofluorogram composition and its use
IPC: G01T1/29
Filed: 1986-11-07
Abstract: The subject invention provides an autofluorography kit composition comprising (i) a first aqueous solution of a water soluble fluor having a formula selected from R-CO₂-X; R-SO₃-X; and R-NH₃-Y; where X and Y are any counterion capable of imparting water solubility, and R is a fluor molecule; and (ii) a second aqueous solution of a precipitator capable of precipitating the water soluble fluor in an electrophoresis gel matrix.
Patent IL-87037-A0 (IL)
Title: 3-demethyl-4-fluoromevalonic acid derivatives,a process for the preparation thereof,pharmaceutical products based on these compounds,the use thereof,and intermediates
IPC: C07H15/18
Filed: 1988-07-08
Abstract: 3-Desmethyl-4-fluoromevalonic acid derivatives of the formula I and the corresponding dihydroxycarboxylic acid derivatives of the formula II 
<IMAGE>
 in which R, X and Y have the meanings given, processes for the preparation of these compounds, their use as medicaments and pharmaceutical preparations are described. Novel intermediates for the preparation of the compounds of the formula I or formula II are additionally described.
Patent IL-88297-A0 (IL)
Title: Water treatment apparatus
IPC: C02F1/28
Filed: 1988-11-06
Abstract: An apparatus for purification and/or sterilization or disinfection of water which has a head (10) with water inlet (12) and outlet (14) openings and a housing (22) secured in water tight relation to said head in which there is a cylindrical filter (18), preferably of activated charcoal. Between the filter and the housing is an outer water channel (28) communicating with the water inlet so that water entering the apparatus is purified by passing through the filter to an inner channel (30) communicating with the water outlet. Water is sterilized or disinfected by an ultraviolet lamp (20) inside the filter over which water that has passed through it flows to the water outlet. The apparatus may be used in multiples which are connected in series or parallel to obtain a greater degree of filtration and disinfection than obtainable in a single unit.
Patent IL-91454-A0 (IL)
Title: Human rhinovirus receptor protein that inhibits virus infectivity,its preparation and pharmaceutical compositions containing it
IPC: C12P21/02
Filed: 1989-08-28
Abstract: A water soluble human rhinovirus (HRV) major receptor preparation comprising detergent-complexed glycoprotein isolated from animal cells, preferably mammalian cells, that express the HRV major receptor and which exhibits the ability to bind to HRV capsids to substantially reduce infectivity of the virus. The purified, water soluble receptor is obtained by extracting cells expressing the receptor with detergent and isolating the solubilized detergent-glycoprotein complexes by binding to monoclonal antibody selective for the HRV receptor protein.
Patent IL-94305-A0 (IL)
Title: Enzymatic removal of a protein amino-terminal sequence
IPC: C07K1/02
Filed: 1990-05-06
Abstract: This disclosure relates to new compounds and to a process for the controlled conversion of such compounds to produce a Protein that comprises an amino acid sequence which is useful as a precursor to human insulin or to a modified human insulin, the amino terminus portion of which sequence does not define a cathepsin C dipeptide removal stop point. The compounds have the formula Met-Y-Protein in which Y is Tyr or Arg.
Patent IL-94822-A0 (IL)
Title: Method and apparatus for determining the characteristics of a fluid having a biological analyte
IPC: G01N21/35
Filed: 1990-06-21
Abstract: The characteristics of a biological fluid sample having an analyte are determined from a model constructed from plural known biological fluid samples. The model is a function of the concentration of materials in the known fluid samples as a function of absorption of wideband infrared energy. The wideband infrared energy is coupled to the analyte containing sample so there is differential absorption of the infrared energy as a function of the wavelength of the wideband infrared energy incident on the analyte containing sample. The differential absorption causes intensity variations of the infrared energy incident on the analyte containing sample as a function of sample wavelength of the energy, and concentration of the unknown analyte is determined from the thus-derived intensity variations of the infrared energy as a function of wavelength from the model absorption versus wavelength function.
Patent AU-PR442101-A0 (AU)
Title: Laser photocoagulator
IPC: A61B3/135
Filed: 2001-04-12
Abstract: An ophthalmic laser system ( 1 ) for performing procedures such as Retinal Photocoagulation and Laser Trabeculoplasty comprises a delivery module ( 2 ) and a console module ( 3 ). The console module includes a treatment laser and optical elements for directing output from the treatment laser to an optical fiber ( 16 ), which is substantially enclosed within the delivery module. The delivery module includes a slit lamp tower ( 6 ), viewing microscope ( 4 ) and alignment optics for directing and focusing output from the optical fiber to a patient treatment zone.
Patent IL-101535-A0 (IL)
Title: Isolation and purification of lantibiotics
IPC: C07K1/20
Filed: 1992-04-09
Abstract: A process for isolating and purifying a lantibiotic from a fermentation broth using a styrene-divinyl-copolymerisate matrix, a strong cation exchanger, means for hydrophobic interaction chromatography and preferably a weak anion exchanger.
Patent IL-102905-A0 (IL)
Title: Compositions and methods for identifying a solution
IPC: A61L12/12
Filed: 1992-08-21
Abstract: A composition and method useful to quickly and effectively indicate whether a functional component such as catalase has been added to a clear solution such as a hydrogen peroxide solution involves compounding with the functional component an effective amount of vitamin B-12 such that when the compounded composition is added to the clear solution, the clear solution turns rose colored. By observing the rose color, the user can determine that the functional component has been added to the clear solution.
Patent IL-127238-A0 (IL)
Title: Cellular internalization of pigr stalk and associated ligands
IPC: C12N15/09
Filed: 1997-05-14
Abstract: Antibody ligands are provided for specific binding to the stalk of a polymeric immunoglobulin receptor (plgr) of a cell with the proviso that the ligand does not substantially bind to secretory component of plgR under physiological conditions. The ligand may be targeted to, into, or across the cell and may comprise a biologically active composition.
Patent IL-137037-A0 (IL)
Title: Acpl dna and polypeptides
IPC: C12N15/24
Filed: 1999-01-22
Abstract: The invention is directed to purified and isolated novel ACPL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
Patent IL-161972-A0 (IL)
Title: Coated particulate cefuroxime axetil compositions
IPC: A61P31/04
Filed: 2002-11-21
Abstract: Composition (A) comprises cefuroxime axetil (I) in the form of particles, entirely enclosed in a coating of at least one lipid (insoluble in water but dispersing or decomposing in contact with gastrointestinal fluid), a bulk sweetener and a binder. (A) Also contains a sweetening system (II) and a texture modifier (III), in amounts so that the bitter taste of (I) is masked.  An Independent claim is included for an orally administered medicament (preferably in aqueous suspension or granule form), comprising (A) together with carriers or excipients.
Patent IL-165678-A0 (IL)
Title: Fungicidal mixtures based on dithianon
IPC: A01N25/04
Filed: 2004-12-02
Abstract: New fungicidal mixtures contain dithianon (I) and at least one 1,2,4-triazole derivative (II) in synergistic amounts, where (II) is metconazole, epoxiconazole, fluquinconazole, tebuconazole (IIa), tetraconazole, difenconazole and/or prothioconazole (preferably metconazole, epoxiconazole or (IIa)). Independent claims are included for: (1) a fungicidal composition comprising the (I)/(II) mixture plus a solid or liquid carrier; and (2) a method for controlling harmful fungi, by applying (I) and (II) to the fungi, their habitat or plants, seeds, soil, surfaces, materials or regions to be protected. ACTIVITY : Fungicide. In tests against Botrytis cinerea in paprika seedlings, (I) at 16 ppm or (IIa) at 4 ppm gave no control, whereas a combination of 16 ppm (I) and 4 ppm (IIa) gave 59% control. MECHANISM OF ACTION : Synergist.
Patent IL-176271-A0 (IL)
Title: Edestin-comprising agent for substitution of blood plasma and a method of its production
IPC: A61K35/16
Filed: 2006-06-12
Abstract: The agent for substitution of the blood plasma is made up of the vegetal protein substance edestin, advantageously a product from the hemp seeds. Advantageously, edestin is a component of the solution comprised of 5%-40% in weight of edestin, 0.5%-7% in weight of inorganic substances, 0.5%-7% in weight of organic substances, hormones, and other substances to 100 % in weight of the colloid solution. According to the method of production of an agent for blood plasma substitution, the vegetal seeds are either cold-pressed or ground to powder and extracted under a compressed gas; the pressed out or extracted vegetal oil is separated, the pressed together or extracted seeds to be relieved of fat and decolorized are extracted by action of the organic solvents, the fat relieved and decolorized substance is then filtered out and exposed to action of the inorganic salts in the water solution and at the temperature from 20 ° C. to 60 ° C., the solution is filtered and edestin is finally isolated from the filtrate. Advantageousl hemp seeds are subjected to the cold pressing and grinding processes and to the gas-assisted pressure extraction. Advantageously, the vegetal seeds are being extracted under the compressed carbon dioxide.